ROBIN DAVID GREY COOPER
Pilots at Dover Rd, Indianapolis, IN
License number
Indiana A4715405
Issued Date
Oct 2016
Expiration Date
Oct 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
6740 Dover Rd, Indianapolis, IN 46220
Professional information
Teicoplanin Derivatives
US Patent:
5916873, Jun 29, 1999
Filed:
Apr 1, 1998
Appl. No.:
9/053848
Inventors:
Robin David Grey Cooper - Indianapolis IN
Nancy June Snyder - Charlottesville IN
Nancy June Snyder - Charlottesville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3800, A61K 3812, C07K 1600, C07K 1700
US Classification:
514 9
Abstract:
The present invention is directed to teicoplanin derivatives of the following general formula, wherein R. sup. 1 and R. sup. 2 are as defined in the specification. ##STR1## These derivatives are useful as antibiotics for the control of gram-positive bacteria.
Teicoplanin Deacylation Process And Product
US Patent:
5936074, Aug 10, 1999
Filed:
Apr 1, 1998
Appl. No.:
9/053668
Inventors:
Barbara Shreve Briggs - Indianapolis IN
Robin David Grey Cooper - Indianapolis IN
Adam Joseph Kreuzman - Greenwood IN
Milton Joseph Zmijewski - Carmel IN
Robin David Grey Cooper - Indianapolis IN
Adam Joseph Kreuzman - Greenwood IN
Milton Joseph Zmijewski - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07H 1708, A61K 3170, A61K 3812
US Classification:
536 71
Abstract:
The present invention is directed to deacyl teicoplanin, and to a process for preparing deacyl teicoplanin by reacting teicoplanin with ECB deacylase. Deacyl teicoplanin can be alkylated to produce compounds useful for their antibacterial activity.
Amides
US Patent:
5919756, Jul 6, 1999
Filed:
May 1, 1997
Appl. No.:
8/847069
Inventors:
Robin David Grey Cooper - Indianapolis IN
Michael John Rodriguez - Indianapolis IN
Nancy June Snyder - Charlottesville IN
Mark James Zweifel - Indianapolis IN
Michael John Rodriguez - Indianapolis IN
Nancy June Snyder - Charlottesville IN
Mark James Zweifel - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3812, A61K 3808, C07K 700, C07K 900
US Classification:
514 8
Abstract:
The present invention is directed to amides of antibiotic A82846B (also known as chloroorienticin A), and of N. sup. 4 -derivatives of A82846B. The present amide compounds are useful as antibacterials, especially for the control of gram positive bacteria; the compounds are particularly useful for the control of resistant bacterial strains, such as vancomycin-resistant-enterococci ("VRE").